Additional immune-checkpoints that may also contribute to tumor immune escape have been introduced such as CD47, B7-H3 (CD276), B7-H4 (VTCN1,B7X), CD39 and CD73 [14, 15]. The gene discussed is ENTPD1; the disease is neoplasm.